Navigation Links
Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011
Date:5/25/2011

,642)$(4,648,303)$(3,203,811)Basic and diluted loss per common share

$(0.06)$(0.04)$(0.25)$(0.21)Weighted average common shares outstanding:Basic and diluted

20,584,66814,946,54018,874,00914,944,354UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS

March 31,20112010AssetsCurrent assets:Cash and cash equivalents & short-term investments

$14,084,150$5,811,269Accounts receivable, net

2,085,2621,287,440Inventories

677,960341,497Income tax receivable

-23,820Other

348,100237,321Total current assets

17,195,4727,701,347Property, plant, and equipment, net

1,210,5421,230,771Intangible assets, net

1,725,1362,533,095Long-term investments

5,508,701-Deferred tax assets

87,031108,530Total assets

$25,726,882$11,573,743Liabilities and Shareholders' EquityCurrent liabilities:Accounts payable

$658,107$485,594Current portion – deferred rent

35,00035,000Income tax payable

6,90110,000Accrued liabilities:Compensation

1,597,657903,057Other

247,451212,028Total current liabilities

2,545,1161,645,679Deferred rent – less current portion

77,272112,500Accrued pension liability

475,845601,037Total liabilities

3,098,2332,359,216Total shareholders' equity

22,628,6499,214,527Total liabilities and shareholders' equity

$25,726,882$11,573,743UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Year ended March 31,20112010Cash flows from operating activities:Net loss

$(4,648,303)$(3,203,811)Adjustments to reconcile net loss to net cash used in operations:Depreciation and amortization

1,119,2271,138,077Loss  on disposal of equipment

5,358853Amortization of premium on marketable securities

18,910-Share-based consulting expense

11,261-Share-based compensation expense

422,893414,507Deferred income taxes

26,192(39,
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Uroplasty to Present at the JMP Securities Research Conference
2. Clinical Studies Results of Uroplasty Products Scheduled for Presentation at Three Professional Meetings
3. Uroplasty Announces Expanded Insurance Coverage of Posterior Tibial Nerve Stimulation (PTNS) Delivered Using the Urgent® PC Neuromodulation System
4. Uroplasty to Present at ROTH Capital Partners 23rd Annual OC Growth Stock Conference
5. Uroplasty Reports Financial Results for the Third Quarter FY2011
6. Uroplasty to Issue Third Quarter 2011 Results on January 27, 2011
7. Uroplasty Announces Addition of Robert Kill to its Board of Directors
8. Additional Regional Medicare Carrier Initiates Coverage for Posterior Tibial Nerve Stimulation (PTNS) Delivered via Uroplastys Urgent® PC Neuromodulation System
9. Uroplasty Inc. Announces CPT® Category I Code and Associated Reimbursement Value for Posterior Tibial Nerve Stimulation
10. Uroplasty Reports Financial Results for the Second Quarter FY2011
11. Uroplasty to Issue Second Quarter 2011 Results on October 27, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion Corporation (the ... it has received commitments from institutional investors to purchase ... common stock in an at-the-market registered direct offering, led ... Company entered into definitive purchase agreements with these investors ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated ... of non-constipating irritable bowel syndrome (IBS). Top-line results ... times daily produced a statistically significant improvement in global ...
... (OTC Bulletin Board: CONX), a worldwide developer and marketer of ... first fiscal quarter ended September 30, 2009, compared with $2,001,896 ... 2.2%. , The first quarter of fiscal 2010 produced operating ... for the first quarter of fiscal 2009. The net loss ...
Cached Medicine Technology:Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome 2Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome 3Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome 4Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome 5Corgenix Reports Financial Results for First Quarter of Fiscal 2010 2Corgenix Reports Financial Results for First Quarter of Fiscal 2010 3
(Date:4/18/2014)... published online in The Gerontologist ... is associated with a decrease in anxiety about death ... control over their lives. In particular, listening to gospel ... death and an increase in sense of control. , ... and men, and individuals of both low- and high-socioeconomic ...
(Date:4/18/2014)... (Seattle, WA April 18, 2014) Benaroya Research ... to research how blocking a particular molecule in metastatic ... and the number of lung metastases. BRI scientists have ... protein can shrink tumors by 60 - 80 percent ... to the lung. The $1.8 million five-year grant comes ...
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2
... death risk, study finds , WEDNESDAY, Aug. 12 (HealthDay ... early non-invasive ventilation after a breathing tube has been ... die, a Spanish study has found. , The study ... had high levels of carbon dioxide in their blood, ...
... , GUANGZHOU, China, Aug. 13 ... Medicine" or "the Company"), a developer,and a leading distributor ... (TCM), nutritional and dietary supplements, and,medical devices and medical ... Second Quarter 2009 Highlights:, ...
... From cranky bosses to incompetent coworkers, traffic jams, inconsiderate drivers, ... way through the typical work day in big cities are enough ... , Tanna Marshall, a holistic health consultant and ... natural health practitioner, offers a collection of tips and advice to ...
... , , THOUSAND OAKS, ... today will summarize data from the submitted Biologic License Applications (BLAs) ... the prevention and treatment of bone loss in breast and prostate ... Food and Drug Administration,s (FDA) Advisory Committee for Reproductive Health Drugs ...
... , NEW YORK, Aug. 13 Terraboost -- ... announced a new program today to provide complimentary touch-free hand ... mitigate risk related to H1N1 swine flu and other disease-causing ... ) , , With the ...
... , ... In September of 2008 SpeechNutrients introduced the ... nutritional support for children with apraxia and speech challenges. A ... Health and Medicine reported that 181 children with verbal apraxia taking ...
Cached Medicine News:Health News:Ventilation After Breathing Tube Removal May Alter Outcomes 2Health News:China Medicine Announces Second Quarter 2009 Results 2Health News:China Medicine Announces Second Quarter 2009 Results 3Health News:China Medicine Announces Second Quarter 2009 Results 4Health News:China Medicine Announces Second Quarter 2009 Results 5Health News:China Medicine Announces Second Quarter 2009 Results 6Health News:China Medicine Announces Second Quarter 2009 Results 7Health News:China Medicine Announces Second Quarter 2009 Results 8Health News:China Medicine Announces Second Quarter 2009 Results 9Health News:China Medicine Announces Second Quarter 2009 Results 10Health News:China Medicine Announces Second Quarter 2009 Results 11Health News:China Medicine Announces Second Quarter 2009 Results 12Health News:China Medicine Announces Second Quarter 2009 Results 13Health News:China Medicine Announces Second Quarter 2009 Results 14Health News:'Living Peacefully in a Big City': Natural Health Practitioner Offers Advice on Maintaining Sanity, Health and Happiness 2Health News:'Living Peacefully in a Big City': Natural Health Practitioner Offers Advice on Maintaining Sanity, Health and Happiness 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 2Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 4Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 5Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 6Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 7Health News:Terraboost Unveils Free H1N1 Risk Mitigation Product 2Health News:Terraboost Unveils Free H1N1 Risk Mitigation Product 3Health News:Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination 2Health News:Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination 3Health News:Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: